Wow. A wearable ultrasound patch for continuous, on the go, high-quality imaging of most parts the human body.
A remarkable new innovation with diverse clinical applications @ScienceMagazine https://t.co/sZBjQYmNQJ @ProfZhaoMIT@ChongheWang@MIT@MITMechE
The diagnosis of platelet storage pool disease is more difficult than many assume, when the defect is not severe. It is good to see guidance on this from the #ISTH SSC published in @JTHjournal. https://t.co/h9x2a6lkgE #platelet
”Modern medicine promotes a .. logically inconsistent message regarding SIDS: .. SIDS is a consequence of unsafe sleep in biologically normal children, but there is vague acknowledgment that important biologic factors are involved in these deaths. https://t.co/NQ4qqORpdm
” ’truth’ is increasingly crowdsourced: if enough people like, share, or choose to believe something, others will accept it as true. [..] it has become imperative for our profession .. to signal clearly who is - and who is not - providing evidence-based information. @NEJM op-ed
Does a healthy lifestyle promote longer life?
A 21-year prospective study of over 20,000 people with almost 9,000 deaths indicates a "dose-response" of 8 lifestyle factors, even in people age 80+
https://t.co/8BGHbz2RB7
since 1992, the FDA accelerated drug approval pathways allows drugs on market before proof of clinical efficacy is secured. BMJ analyses shows 112 of 253 drugs are still not confirmed clinically effective https://t.co/JnqwkXymi9 @bmj_latest
my alma mater @UniUtrecht abandons impact factor in hiring and promotion decisions in favour of rewarding teamwork and open science https://t.co/lo3kD7OtrD
Have you explored the new modules on the ISTH Lab Core Curriculum? The new sections cover specialized testing for thrombotic disorders, and understanding the changes to coagulation. https://t.co/RxZn4dvaRt
"EMI [the company best known for music recordings who produced the first CT scan] originally estimated that the worldwide market for CT scanners would be about 25 machines" @NEJM https://t.co/7wAxVuZKTv
This is an interesting read in anybody who is involved in the management of bleeding patients. The author questions the benefit of tranexamic acid (TXA) in most situations, including where large RCTs have shown subgroup benefit. https://t.co/hG0rU8VduR